pcaggs vector - Anopheles Database

SARS-CoV-2 Spike Receptor-Binding Domain: Plasmid Design, Expression and Molecular Applications

The spike (S) glycoprotein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) plays a central role in viral infection by mediating interactions between the virus and host cell receptors. Its receptor-binding domain (RBD) is particularly important because it directly recognizes angiotensin-converting enzyme 2 (ACE2), the primary host-cell receptor involved in viral entry.

Understanding the molecular structure, expression, and biological properties of the SARS-CoV-2 spike RBD is essential for investigating viral attachment, host-pathogen interactions, antibody recognition, and immune responses. Recombinant DNA technologies provide valuable tools for producing and characterizing this viral protein domain under controlled experimental conditions.

The NR-52309 plasmid is designed to encode the SARS-CoV-2 spike receptor-binding domain and provides a molecular biology resource for research involving viral protein expression and immunological investigations.

Structure and Biological Function of the SARS-CoV-2 Spike Protein

The SARS-CoV-2 spike glycoprotein is a major structural component of the viral envelope. It forms a trimeric complex composed of three protein subunits and is responsible for recognizing host-cell receptors and facilitating viral membrane fusion.

The spike protein is functionally divided into two major regions:

  • S1 subunit: Contains the receptor-binding domain responsible for recognizing and interacting with the host ACE2 receptor.

  • S2 subunit: Contains the molecular machinery required for fusion between viral and host-cell membranes.

The interaction between the spike protein and ACE2 represents an essential step in the viral entry process. This molecular interaction has therefore become a major focus of research into SARS-CoV-2 infection, neutralizing antibodies, and antiviral strategies.

Evolution of the SARS-CoV-2 spike protein in utilizing host transmembrane  serine proteases - ScienceDirect

Receptor-Binding Domain (RBD): Molecular Characteristics

The receptor-binding domain is a functional region within the S1 subunit of the SARS-CoV-2 spike glycoprotein. It is responsible for direct recognition of the ACE2 receptor through specific molecular interactions.

The NR-52309 plasmid encodes the RBD corresponding to amino acids 319–541 of the Wuhan-Hu-1 spike protein sequence (GenBank accession MN908947).

The construct incorporates several molecular elements:

  • The N-terminal signal sequence of the spike protein to support protein secretion.

  • The receptor-binding domain spanning amino acids 319–541.

  • A C-terminal hexa-histidine tag to facilitate protein purification and detection.

  • A mammalian codon-optimized coding sequence to support recombinant protein expression.

These features make the construct suitable for molecular biology research involving recombinant SARS-CoV-2 spike RBD production.

The antigenic anatomy of SARS-CoV-2 receptor binding domain - ScienceDirect

NR-52309 Plasmid Design and Vector Architecture

The NR-52309 construct is based on the pCAGGS mammalian expression vector, which is commonly used in recombinant protein expression studies.

The plasmid contains the spike RBD coding sequence under the control of a mammalian expression promoter. Its design incorporates genetic elements required for protein production and bacterial plasmid propagation.

The principal components include:

1. Spike RBD Coding Sequence

The insert encodes the receptor-binding domain of the SARS-CoV-2 spike glycoprotein, corresponding to amino acids 319–541.

2. N-Terminal Signal Sequence

The spike protein signal sequence is fused to the RBD coding region to support entry into the secretory pathway during mammalian expression.

3. C-Terminal Hexa-Histidine Tag

The six-histidine tag provides an affinity handle that can facilitate recombinant protein purification and analytical detection.

4. pCAGGS Mammalian Expression Vector

The pCAGGS backbone provides regulatory elements supporting expression in mammalian cells.

Expression Vector - an overview | ScienceDirect Topics

5. Beta-Lactamase Selection Marker

The plasmid contains the bla gene, which encodes beta-lactamase and provides ampicillin resistance for bacterial transformant selection in Escherichia coli.

The resulting plasmid has an approximate size of 5,490 base pairs.

Advances in the detection of β-lactamase: A review - ScienceDirect

Codon Optimization and Recombinant Protein Expression

Codon optimization is an important consideration in recombinant protein production. Different organisms exhibit variations in codon usage preferences, which can influence the efficiency of heterologous gene expression.

For the NR-52309 construct, the spike RBD coding sequence was optimized for mammalian expression. This modification is intended to improve compatibility with mammalian cellular translation machinery while preserving the encoded amino acid sequence.

The expression vector also includes a signal sequence that supports the routing of the recombinant protein through the cellular secretory pathway.

These molecular design characteristics are relevant to research applications requiring recombinant spike RBD production, protein characterization, and immunological analysis.

Applications in SARS-CoV-2 Research and Immunology

Recombinant spike RBD constructs are valuable research tools for investigating the molecular mechanisms underlying SARS-CoV-2 infection and immune recognition.

ACE2 Receptor-Binding Studies

The RBD is directly involved in spike recognition of ACE2. Recombinant RBD proteins can therefore support experimental investigations of receptor-binding interactions and molecular recognition.

Neutralizing Antibody Research

The spike protein is an important target of neutralizing antibodies. RBD-based research tools can contribute to the characterization of antibody binding, antigen recognition, and neutralization-associated immune responses.

Vaccine Development Research

The spike RBD has been investigated as an antigenic component in several vaccine research strategies. Recombinant expression systems support the production and characterization of antigen candidates for preclinical research.

Protein Purification and Characterization

The C-terminal hexa-histidine tag facilitates affinity-based purification approaches and supports downstream biochemical characterization of recombinant proteins.

Molecular Virology

RBD constructs provide useful experimental resources for studying viral attachment, receptor recognition, and host-pathogen interactions.

Bacterial Propagation and Plasmid Selection

Although NR-52309 is designed for mammalian expression, the plasmid is produced and propagated in Escherichia coli.

The bla gene provides a selectable marker through beta-lactamase-mediated ampicillin resistance. This feature allows the identification and selection of bacterial transformants carrying the plasmid.

Following bacterial propagation, plasmid DNA is extracted and prepared for research applications. The plasmid has an approximate molecular size of 5,490 base pairs, and its complete sequence is available through the BEI Resources product documentation.

It is important to distinguish bacterial plasmid propagation from mammalian protein expression: the bacterial system is used to amplify the plasmid DNA, whereas the mammalian expression vector is intended to support production of the encoded recombinant protein in suitable mammalian cells.

Plasmid DNA Storage and Handling Considerations

The NR-52309 product is supplied as plasmid DNA in TE buffer containing 10 mM Tris-HCl and 1 mM EDTA at pH 8.0.

Appropriate handling is important to maintain plasmid DNA integrity and ensure reliable downstream experimental use.

The supplied vial should be centrifuged before opening, as indicated in the product documentation. The plasmid DNA is intended to be propagated in Escherichia coli before use in mammalian expression applications.

Researchers should consult the official product documentation for the complete plasmid sequence, handling instructions, and additional application-specific information.

Research Perspectives in SARS-CoV-2 Spike Protein Biology

Research involving the SARS-CoV-2 spike glycoprotein continues to provide important insights into viral evolution, receptor recognition, and host immune responses.

Changes in the spike protein sequence can influence interactions with ACE2 and modify antigenic properties recognized by the immune system. Consequently, molecular characterization of the RBD remains relevant to studies investigating viral variants, antibody recognition, and host-pathogen interactions.

Recombinant expression technologies, plasmid engineering, and protein characterization methods continue to support these investigations by providing controlled experimental systems for studying specific viral protein regions.

Frequently Asked Questions About SARS-CoV-2 Spike RBD Plasmids

1. What is the SARS-CoV-2 spike RBD?

The receptor-binding domain is a region of the spike glycoprotein responsible for recognizing the ACE2 receptor on host cells.

2. What does NR-52309 encode?

NR-52309 encodes the SARS-CoV-2 spike receptor-binding domain corresponding to amino acids 319–541 of the Wuhan-Hu-1 reference sequence, together with an N-terminal signal sequence and a C-terminal hexa-histidine tag.

3. What is the purpose of the His-tag?

The hexa-histidine tag provides an affinity handle that can facilitate recombinant protein purification and detection.

4. Why is the coding sequence codon optimized?

Codon optimization improves the compatibility of the coding sequence with mammalian expression systems while maintaining the encoded protein sequence.

5. What is the function of the bla gene?

The bla gene encodes beta-lactamase, providing ampicillin resistance for the selection of plasmid-containing Escherichia coli transformants.

6. What is the approximate size of the NR-52309 plasmid?

The plasmid is approximately 5,490 base pairs in length.

Conclusion

The NR-52309 plasmid represents a molecular biology resource for investigating the SARS-CoV-2 spike receptor-binding domain and its role in host-cell recognition. Its design combines a mammalian codon-optimized RBD sequence, an N-terminal signal peptide, a C-terminal hexa-histidine tag, and the pCAGGS expression vector backbone.

Through its molecular architecture and bacterial selection marker, this construct supports plasmid propagation and research involving recombinant spike RBD expression. It provides a useful tool for studies of ACE2 interactions, antigen characterization, neutralizing antibody recognition, and SARS-CoV-2 molecular biology.